However, a recently patented specific PDE3A inhibitor compound has been identified (DNMDP) that appears to induce apoptosis in a set of NCI-60 cancer cells, including lung cancer cells, by enhancing the interaction of PDE3A with SLFN12. The gene discussed is PDE3A; the disease is cancer.